KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Assets (2016 - 2026)

Medtronic's Assets history spans 12 years, with the latest figure at $91.5 billion for Q1 2026.

  • For Q1 2026, Assets rose 1.68% year-over-year to $91.5 billion; the TTM value through Jan 2026 reached $91.5 billion, up 1.68%, while the annual FY2025 figure was $91.7 billion, 1.89% up from the prior year.
  • Assets for Q1 2026 was $91.5 billion at Medtronic, roughly flat from $91.3 billion in the prior quarter.
  • Across five years, Assets topped out at $94.1 billion in Q1 2023 and bottomed at $89.7 billion in Q3 2024.
  • The 5-year median for Assets is $90.9 billion (2023), against an average of $91.1 billion.
  • The largest annual shift saw Assets decreased 5.62% in 2022 before it increased 2.54% in 2023.
  • A 5-year view of Assets shows it stood at $93.2 billion in 2022, then decreased by 3.38% to $90.1 billion in 2023, then dropped by 0.05% to $90.0 billion in 2024, then rose by 1.45% to $91.3 billion in 2025, then rose by 0.15% to $91.5 billion in 2026.
  • Per Business Quant, the three most recent readings for MDT's Assets are $91.5 billion (Q1 2026), $91.3 billion (Q4 2025), and $91.0 billion (Q3 2025).